Where can I find MLAB's financial statements?

Mesa Laboratories, Inc. (MLAB)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for MLAB?

Mesa Laboratories, Inc. (MLAB) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does MLAB update its statements?

Mesa Laboratories, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

MLAB

Mesa Laboratories, Inc.

NASDAQ·Medical, Specialties · Healthcare

$124.32$0.44−0.35%

After hours·$124.32+0.00%

Market cap$695.68M·Market closed·Aug 24 8:00 PM UTC

USD · values shown as reported

Line item	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Revenue	$184.34M+37.6%	$219.08M+18.8%	$216.19M−1.3%	$240.98M+11.5%	$249.13M+3.4%
Cost of revenue	$75.25M+60.4%	$85.39M+13.5%	$82.94M−2.9%	$90.11M+8.6%	$90.86M+0.8%
Gross profit	$109.09M+25.4%	$133.69M+22.6%	$133.25M−0.3%	$150.87M+13.2%	$158.27M+4.9%
Research & development	$15.77M+51.8%	$20.49M+30.0%	$19.30M−5.8%	$19.52M+1.1%	$20.31M+4.0%
General & administrative	$60.31M+31.7%	$72.44M+20.1%	$72.87M+0.6%	$73.33M+0.6%	$78.66M+7.3%
Selling & marketing	$28.31M+53.2%	$37.44M+32.2%	$38.63M+3.2%	$41.68M+7.9%	$40.79M−2.1%
SG&A (combined)	$88.62M+37.9%	$109.88M+24.0%	$111.49M+1.5%	$115.02M+3.2%	$119.45M+3.9%
Other operating expenses	—	—	$274.53M	—	—
Total operating expenses	$104.39M+39.8%	$130.37M+24.9%	$405.33M+210.9%	$134.53M−66.8%	$139.76M+3.9%
Operating income	$4.70M−62.0%	$3.32M−29.4%	−$272.08M−8,295.0%	$16.34M+106.0%	$18.51M+13.3%
Interest expense	$3.89M−51.6%	$4.77M+22.8%	$5.70M+19.4%	$11.86M+108.2%	$10.69M−9.8%
Other income / (expense), net	−$1.13M+88.8%	−$3.71M−228.8%	−$3.57M+3.7%	−$10.38M−190.4%	−$6.50M+37.4%
Income before tax	$3.57M+55.2%	−$389.00K−110.9%	−$275.65M−70,760.7%	$5.96M+102.2%	$12.01M+101.5%
Income tax expense	$1.70M+275.4%	−$1.32M−177.5%	−$21.40M−1,522.6%	$7.94M+137.1%	$5.30M−33.2%
Net income	$1.87M−42.9%	$930.00K−50.3%	−$254.25M−27,438.3%	−$1.97M+99.2%	$6.71M+440.0%

EPS (basic)	$0.36−45.5%	$0.17−52.8%	−$47.20−27,864.7%	−$0.36+99.2%	$1.22+438.9%
EPS (diluted)	$0.35−45.3%	$0.17−51.4%	−$47.20−27,864.7%	−$0.36+99.2%	$1.21+436.1%
Weighted avg shares (basic)	5,212,000	5,321,000	5,386,000	5,429,000	5,514,000
Weighted avg shares (diluted)	5,335,000	5,361,000	5,386,000	5,429,000	5,565,000

Depreciation & amortization	$25.07M+41.9%	$33.13M+32.2%	$31.57M−4.7%	$24.53M−22.3%	$23.27M−5.1%
EBITDA	$32.53M+16.2%	$37.52M+15.3%	−$238.38M−735.4%	$42.35M+117.8%	$35.29M−16.7%

Frequently Asked Questions About MLAB

Where can I find MLAB's financial statements?: Mesa Laboratories, Inc. (MLAB)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for MLAB?: Mesa Laboratories, Inc. (MLAB) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does MLAB update its statements?: Mesa Laboratories, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2022

FY 2023

FY 2024

FY 2025

FY 2026

Trend

Revenue

$184.34M+37.6%

$219.08M+18.8%

$216.19M−1.3%

$240.98M+11.5%

$249.13M+3.4%

Cost of revenue

$75.25M+60.4%

$85.39M+13.5%

$82.94M−2.9%

$90.11M+8.6%

$90.86M+0.8%

Gross profit

$109.09M+25.4%

$133.69M+22.6%

$133.25M−0.3%

$150.87M+13.2%

$158.27M+4.9%

Research & development

$15.77M+51.8%

$20.49M+30.0%

$19.30M−5.8%

$19.52M+1.1%

$20.31M+4.0%

General & administrative

$60.31M+31.7%

$72.44M+20.1%

$72.87M+0.6%

$73.33M+0.6%

$78.66M+7.3%

Selling & marketing

$28.31M+53.2%

$37.44M+32.2%

$38.63M+3.2%

$41.68M+7.9%

$40.79M−2.1%

SG&A (combined)

$88.62M+37.9%

$109.88M+24.0%

$111.49M+1.5%

$115.02M+3.2%

$119.45M+3.9%

Other operating expenses

—

$274.53M

—

Total operating expenses

$104.39M+39.8%

$130.37M+24.9%

$405.33M+210.9%

$134.53M−66.8%

$139.76M+3.9%

Operating income

$4.70M−62.0%

$3.32M−29.4%

−$272.08M−8,295.0%

$16.34M+106.0%

$18.51M+13.3%

Interest expense

$3.89M−51.6%

$4.77M+22.8%

$5.70M+19.4%

$11.86M+108.2%

$10.69M−9.8%

Other income / (expense), net

−$1.13M+88.8%

−$3.71M−228.8%

−$3.57M+3.7%

−$10.38M−190.4%

−$6.50M+37.4%

Income before tax

$3.57M+55.2%

−$389.00K−110.9%

−$275.65M−70,760.7%

$5.96M+102.2%

$12.01M+101.5%

Income tax expense

$1.70M+275.4%

−$1.32M−177.5%

−$21.40M−1,522.6%

$7.94M+137.1%

$5.30M−33.2%

Net income

$1.87M−42.9%

$930.00K−50.3%

−$254.25M−27,438.3%

−$1.97M+99.2%

$6.71M+440.0%

EPS (basic)

$0.36−45.5%

$0.17−52.8%

−$47.20−27,864.7%

−$0.36+99.2%

$1.22+438.9%

EPS (diluted)

$0.35−45.3%

$0.17−51.4%

−$47.20−27,864.7%

−$0.36+99.2%

$1.21+436.1%

Weighted avg shares (basic)

5,212,000

5,321,000

5,386,000

5,429,000

5,514,000

Weighted avg shares (diluted)

5,335,000

5,361,000

5,386,000

5,429,000

5,565,000

Depreciation & amortization

$25.07M+41.9%

$33.13M+32.2%

$31.57M−4.7%

$24.53M−22.3%

$23.27M−5.1%

EBITDA

$32.53M+16.2%

$37.52M+15.3%

−$238.38M−735.4%

$42.35M+117.8%

$35.29M−16.7%